Drug intelligence / Profile preview

Redisolv

Development stage
Unknown
Lead developer
Aurora Biofarma
Modality
Small Molecules
Administration
Oral
01

Overview

Redisolv is a combination dietary supplement and Class IIa medical device developed by Aurora Biofarma for the management of irritable bowel syndrome (IBS) and the support of normal intestinal function. The product contains two primary active components: partially hydrolyzed guar gum (PHGG) and simethicone. PHGG is a water-soluble prebiotic fiber that helps normalize the intestinal microbiota and regulate bowel transit. Simethicone is an anti-foaming agent that works by reducing the surface tension of gas bubbles within the gastrointestinal tract, facilitating their dispersion and elimination. Together, these ingredients are intended to alleviate common IBS symptoms such as bloating, flatulence, abdominal pain, and cramping. Redisolv is typically commercialized in a stick pack format for oral administration.

Brand names
Redisolv

Beyond the preview

Go deeper on Redisolv.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Redisolv.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call